the aid library

LIST OPTIONS

Filter

3632

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (139)

View PDF (128)

Laboratory manual for yellow fever
recommended

World Health Organization WHO (2024) C_WHO

This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh... more

Download (215)

View PDF (294)

Story of change in four countries Building capacity for integrating mental health care within health services across humanitarian settings

World Health Organization WHO; mGAP (2021) C_WHO

The world is facing an unprecedented range of emergencies. In reaction to these complex adversities, many people experience considerable distress and impairment, and a minority may even go on to develop mental health conditions. Meanwhile, those with pre-existing mental health conditions may experie... more

External Link

Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation–Lancet Commission on planetary health | Sustainable Development Goals - Resource Centre

Whitmee S., Haines A. et al. (2015) C2

By almost any measure, human health is better now than at any time in history. Life expectancy has soared from 47 years in 1950–1955, to 69 years in 2005–2010, and death rates in children younger than 5 years of age have decreased substantially, from 214 per thousand live births in 1950–1955, ... more

Download (303)

View PDF (556)

Sierra Leone - Multiple Indicator Cluster Survey 2017: Survey Findings Report

UNICEF; Global MICS Programme; Government of Sierra Loene, WHO; et al. (2018) C1

Download (161)

View PDF (210)

Managers Who Lead Handbook Improving Health Services

Management Sciences for Health (2008) C1

Managers Who Lead empowers health managers at all levels of an organization to lead teams to face challenges and achieve results. It answers questions such as: How can I lead and manage more effectively? How do I create a shared vision and a clear path for achieving it? What can I do to improve work... more

External Link

An Independent Review of World Bank Support for Capacity Building in Africa: The Case of Benin

Corporate Evaluation and Methods Operations Evaluation Department World Bank (2005) C2

Relevance and effectiveness of World Bank support for public sector capacity building in Sub-Saharan Africa from 1995 to 2004. Benin is part of a six country case study.

Download (1566)

View PDF (1227)

Applied research concerning inclusion of persons with disabilities in systems of social protection

London School of Hygiene and Tropical Medicine and the Technische Universität München; REPOA GIZ; German Federal Ministry for Economic Cooperation and Development (BMZ) (2015) C1

Social Protection Policy Analysis, Tanzania

Download (486)

View PDF (797)

Ten Years of Traditional Contraceptive Method Use in the Philippines: Continuity and Change

M. Paz N. Marquez; M.M.M. Kabamalan and E.P. Laguna USAID (2017) C1

Demographic Health Survey Working Paper 2017 No. 130

Download (1440)

View PDF (475)

Child Protection Case Management Training Manual

The Government of Malawi PEPFAR; UNICEF (2017) C1

This five-day child protection case management training manual was developed to meet the needs of community child protection workers and other social workers working in tandem with the justice, health and law enforcement systems in Malawi.

Download (144)

View PDF (209)

Protecting the right to legal capacity in mental health and related services WHO QualityRights training to act, unite and empower for mental health (P I L O T V E R S I O N)

World Health Organization WHO (2017) C_WHO

This document provides training and guidance on legal capacity and how supported decision making, recovery plans and advance plans help to avoid involuntary detention and treatment and ensure people are able to exercise their right to legal capacity.

Download (398)

View PDF (916)

Malaria diagnostics technology and market landscape. 3rd edition
recommended

UNITAID World Health Organization (WHO) (2016) C_WHO

Download (236)

View PDF (439)

Safe & sound: What states can do to ensure respect for the best interests of unaccompanied and separated children in Europe

UNHCRIOM UNICEF (2014)

Unaccompanied and separated children leave their countries of origin for a variety of reasons. They may be fleeing from persecution, armed conflict, exploitation or poverty. They may have been sent by members of their family or decided to leave on their own – be it to ensure their survival, or t... more

Download (225)

View PDF (286)

CONSENSUS DOCUMENT FOR MANAGEMENT OF Non Hodgkin’s Lymphoma (High Grade)

Indian Council of Medical Research (ICMR) (2016) C1

Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec... more